— Know what they know.
Not Investment Advice

ANNX NASDAQ

Annexon, Inc.
1W: -7.7% 1M: +1.6% 3M: -25.6% YTD: -21.1% 1Y: +21.3% 3Y: +112.6% 5Y: -82.2%
$3.76
+0.06 (+1.62%)
After Hours: $3.73 (-0.03, -0.93%)
Weekly Expected Move ±11.9%
$3 $3 $4 $4 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 37 · $606.2M mcap · 176M float · 2.06% daily turnover · Short 50% of daily vol
Credit Risk of going bust: higher than 50% of companies Debt: 3.9% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 99.4%), Annexon, Inc. would be worth roughly what it owes.
Total debt $24.7M against a stock market value of $606.2M.
Distance to default 5.08 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $12.3M (short-term plus half of long-term), stock volatility 74.1%; Altman Z'' -11.11. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$278M -20.7% ▼
5Y CAGR: -4.9%
Total Liabilities
$66M +15.7% ▲
5Y CAGR: +41.4%
Shareholders Equity
$212M -27.8% ▼
5Y CAGR: -9.3%
Cash & Investments
$238M -23.6% ▼
5Y CAGR: -7.5%
Total Debt
$26M -9.6% ▼
Net Debt
-$136M -561.8% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$75M$140M$225M$49M$162M
Short-Term Investments$168M$103M$35M$263M$76M
Cash & ST Investments$243M$243M$260M$312M$238M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$463K$203K$63K$1M$4M
Total Current Assets$248M$248M$264M$316M$242M
Property, Plant & Equip.$38M$36M$33M$29M$26M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$1M$0$0$0
Other Non-Current Assets$1M$0$1M$4M$10M
Total Non-Current Assets$39M$37M$34M$34M$35M
Total Assets$287M$285M$298M$350M$278M
— Liabilities —
Accounts Payable$11M$7M$5M$10M$15M
Short-Term Debt$0$0$0$0$3M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$2M$180K$6M$6M$40M
Total Current Liabilities$22M$22M$18M$31M$43M
Long-Term Debt$0$0$0$0$23M
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$33M$32M$29M$26M$23M
Total Liabilities$55M$54M$47M$57M$66M
— Equity —
Common Stock$39K$48K$78K$109K$149K
Retained Earnings-$296M-$438M-$572M-$711M-$917M
Accumulated OCI-$180K-$372K-$52K$10K-$29K
Total Stockholders Equity$232M$231M$251M$293M$212M
Total Liabilities & Equity$287M$285M$298M$350M$278M
— Key Metrics —
Total Debt$35M$33M$31M$29M$26M
Net Debt-$40M-$107M-$194M-$21M-$136M
Total Investments$168M$104M$35M$263M$76M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms